Sumalpong, Briggs Owen M.
HRN: 23-00-15 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/29/2023
MUPIROCIN 2%, 15G (TUBE)
11/29/2023
12/06/2023
TOPICAL
15g
BID
ABI
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: BloodstreamSkin & Soft TissueProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes